Objective To evaluate the expression of genes related to nuclear excision (ERCC8, XPA and XPC), homologous recombination and non-homologous end-joining (ATM, BRCA1, BRCA2 and LIG4) repair mechanisms, using quantitative PCR methodologies, and it relation with bone marrow cellularity in myelodysplastic syndrome (MDS). Methods and results A total of 51 adult de novo patients with MDS (3 refractory anaemia (RA), 11 refractory anaemia with ringed sideroblasts (RARS), 28 refractory cytopenia with multilineage dysplasia (RCMD), 3 refractory anaemia with excess blasts type I (RAEB-I), 5 refractory anaemia with excess blasts type II (RAEB-II), and 1 chronic myelomonocytic leukaemia (CMML) were evaluated. For karyotype, 16.2% patients were defined as very low prognosis, 59.5% low risk, 8.1% intermediate risk, 5.4% high risk and 10.8% very high risk. For bone marrow cellularity, 17.6%, 17.6% and 64.7% presented as hypocellular, normocellular and hypercellular, respectively. Patients with hypocellular MDS had significantly decreased expression of ATM ( p=0.000), BRCA1 ( p=0.014), BRCA2 ( p=0.003), LIG4 ( p=0.004) and ERCC8 ( p=0.000) than those with normocellular/hypercellular bone marrow, whereas XPA ( p=0.049) and XPC ( p=0.000) genes were increased. In patients with hypoplastic MDS, a low expression of ATM ( p=0.0268), LIG4 ( p=0.0199) and ERCC8 ( p=0.0493) was significantly associated with the presence of chromosomal abnormalities. We detected positive correlations between BRCA1 and BRCA2 (r=0.416; p=0.007), ATM and LIG4 (r=0.472; p=0.001), LIG4 and BRCA1 (r=0.333; p=0.026), LIG4 and BRCA2 (r=0.334; p=0.025), ATM and XPA (r=0.377; p=0.008), ATM and XPC (r=0.287; p=0.046), LIG4 and XPC (r=0.371; p=0.007) and XPA and XPC genes (r=0.895; p=0.0000). We also found among all patients evaluated that correlation with LIG4 occurred most often. Conclusions These correlations demonstrate the important intrinsic relations between single and double DNA strand breaks genes in MDS, emphasising that these genes are related to MDS pathogenesis.
INTRODUCTION
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal haematopoietic stem cell disorders characterised by peripheral cytopenias due to ineffective haematopoiesis. [1] [2] [3] Bone marrow cellularity in patients with MDS is usually hypercellular or normocellular. 4 According to WHO, 10-15% of patients with MDS can present hypocellular bone marrow, which has prognostic significance for hypoplastic MDS (hMDS). 5 6-8 Schemenau et al 9 evaluated the prognostic importance of cellularity among 1270 patients with MDS and showed that for cases with hypercellular, normocellular and hypocellular bone marrow there was a significant difference in median survival of 25 months, 42 months and 38 months, respectively. 9 Acute myeloid leukaemia progression rates were 33% after 2 years (hypercellular), whereas normocellular and hypocellular cases showed a progression of only 19%. These results suggest that hypercellular bone marrow in MDS is related to a poor prognosis. 9 Patients with hypocellular bone marrow are usually younger, have immune abnormalities such as vasculitis, pyoderma and respond to antithymocyte globulin (Atgam) treatment. [10] [11] [12] In a study of the pathogenesis of hMDS, Young et al, 13 reported that T cells affect bone marrow destruction as in aplastic anaemia, reinforcing hMDS as a distinct entity with a different prognosis.
DNA repair is an important mechanism for maintaining the integrity of multicellular organisms and for ensuring genomic stability.
14 DNA damage constantly arises from DNA replication, spontaneous chemical reactions and assaults by external or metabolism-derived agents. 15 16 At least four main, partially overlapping damage repair pathways operate in mammals: nucleotide-excision repair (NER), base excision repair (BER), homologous recombination (HR) and non-homologous endjoining (NHEJ). NER and BER are related to single-strand lesion and HR and NHEJ, to doublestrand breaks (DSBs). DSBs are mutagenic DNA lesions 3 14 17 and are considered to exert important biological effects on the formation of chromosomal aberrations, cell death and transformation, 3 14 17 which are common features of MDS. NER eliminates helix-distorting DNA damage, a broad category of damage that affects one of the two DNA strands. 15 Problems in NER are also related to cancer and senescence. 15 We previously demonstrated that polymorphisms of DNA repair genes related to HR are associated with the pathogenesis of MDS. 18 19 We found that the polymorphisms of ATM, RAD51, XRCC5 and XRCC6 are associated with the genesis and aetiology of MDS. 18 19 Importantly, we recently showed that these polymorphisms are functional, influencing the level of expression of ATM, XRCC6 and LIG4. 20 The aim of this study was to evaluate the relation between expression of genes related to NER (ERCC8, XPA and XPC), HR and NHEJ (ATM, BRCA1, BRCA2 and LIG4) repair mechanisms and bone marrow cellularity in MDS.
PATIENTS AND METHODS Patients
Fifty-one adult de novo patients with MDS were diagnosed at Federal University of Ceara according to WHO. 10 The patients were evaluated according to WHO classification 10 and the International Prognosis Score System revised (IPSS-R). 21 Bone marrow cellularity was assessed on biopsy specimens and was stratified as hypocellular, normocellular and hypercellular, in relation to the patient's age. Hypocellularity in patients with MDS was defined as <30% in those aged <70 years, and 20% in patients >70% years, according to the established criteria of the European consensus on grading bone marrow fibrosis and assessment of cellularity. 22 The study was approved by the ethics committee of the Federal University of Ceara (No. 1.292.509) and conducted according to the Declaration of Helsinki. Informed consent was obtained from all participants included in this study.
Cytogenetic analysis
Conventional G-band karyotype analysis was performed on bone marrow cells of 51 de novo patients with MDS according to the protocol already established in our laboratory. 23 Briefly, cultures were established in RPMI 1640 medium (Gibco, Grand Island, New York, USA) containing 30% fetal calf serum. For the 24-hour culture, colcemid was added at a final concentration of 0.05 μg/mL for the final 30 min. After harvesting, the cells were exposed to a hypotonic KCl solution (0.068 mol/L) and fixed with Carnoy buffer (acetic acid/methanol in a 1:3 proportion). The slides were prepared and stained using Giemsa solution. A minimum of 20 metaphases was analysed whenever possible. The karyotype was prepared using a CytoVision Automated Karyotyping System (Applied Imaging, San Jose, California, USA) and described according to the International System for Human Cytogenetic Nomenclature (2013).
Total RNA extraction
Total RNA extractions from isolated mononuclear cells (bone marrow), obtained from patients with MDS, were performed with TRizol Reagent (Invitrogen, Carlsbad, California, USA), according to the manufacturer's protocol. Student's t-test or one-way analysis of variance with Tukey/ Games-Howell post hoc test were used to analyse the associations between gene expression and the variables. The homogeneity of variances for all variables was tested by Levene's test. Multinomial logistic regression (MLR) analysis was used to estimate the ORs for each gene that might contribute to cellularity.
The best DNA repair expression cutoff point predicting MDS overall survival was calculated using the web-based Cutoff Finder software 9 (Cutoff Finder-http://molpath.charite.de/cutoff/index. jsp) by Kaplan-Meier curve analysis based on the log-rank test.
Pearson's correlation test was used to obtain r and r 2 values. Statistical analyses were performed using the GraphPad Prism 5 (GraphPad Prism software, La Jolla, California, USA) and SPSS 20.0 (SPSS Inc, Chicago, Illinois, USA) computer software programs. Probability level ( p value) <0.05 was assumed.
RESULTS Patients
Characteristics of the patients with MDS are shown in table 1. A total of 51 adult de novo patients with MDS (3 refractory anaemia (RA), 11 refractory anaemia with ringed sideroblasts (RARS), 28 refractory cytopenia with multilineage dysplasia (RCMD), 3 refractory anaemia with excess blasts type I (RAEB-I), 5 refractory anaemia with excess blasts type II (RAEB-II), and 1 chronic myelomonocytic leukaemia (CMML) were analysed according to WHO classification. 10 Cytogenetic analyses were performed in 37/51 (72.5%) patients. Of those, 21 (table 1) . Table 2 Gene expression of patients with MDS according to bone marrow cellularity 
†
Asterisk indicates significant differences (p<0.05) between groups. *These genes were analysed for the hypocellular versus normocellular+hypercellular groups. †These data were analysed by one-way analysis of variance (ANOVA) with the Games-Howell post hoc test. ‡These data were analysed by one way ANOVA with the Tukey post hoc test. §These data were analysed by a two-sided Student t test. BM, bone marrow; DSB, double-strand break genes related to double DNA strand break repair pathway; MDS, myelodysplastic syndrome; SSB, single-strand break genes related to single DNA strand break repair pathway.
For bone marrow cellularity, 9 (17.6%) patients presented hypocellular bone marrow, 9 (17.6%) normocellular and 33 (64.7%) hypercellular (table 1) . For patients with hypocellular MDS, 5/7 (71.4%) had chromosomal abnormalities (table 1) , whereas for patients with normocellular/hypercellular hMDS 11/30 (36.7%) were found to have abnormalities (table 1) . We determined that hMDS was associated with a lower count of neutrophils ( p=0.000) and younger patients ( p=0.000) (table 1). mRNA expression of DNA repair genes in relation to bone marrow cellularity
We evaluated mRNA expression of ATM, BRCA1, BRCA2, LIG4, ERCC8, XPA and XPC genes related to the bone marrow cellularity analysis. The mRNA expressions of patients with MDS are shown in table 2.
Patients with hypocellular MDS presented significantly lower ATM ( p=0.000; 95% CI=0.001330 to 0.003914) mRNA expression levels than patients with hypercellular bone marrow (figure 1A). We also detected an important decrease of BRCA1 expression ( p=0.014; 95% CI 0.000514 to 0.005521), BRCA2 ( p=0.003; 95% CI 0.000709 to 0.004136), LIG4 ( p=0.004; 95% CI 0.000162 to 0.000899) and ERCC8 ( p=0.000; 95% CI 0.000070 to 0.000245) genes (figure 1B-E) in hMDS.
On the other hand, we found that there is an increase of XPA ( p=0.049; 95% CI 0.000000182 to 0.001064) and XPC ( p=0.000; 95% CI 0.002192 to 0.006704) expression in hMDS (figure 1F, G).
Analysis of karyotype in patients with hypoplastic MDS in relation to DNA repair genes
Patients with hMDS who showed low expression of ATM (p=0.0268; 95% CI 0.005891 to 0.0006105), LIG4 (p=0.0199; 95% CI 0.001239 to 0.0001663) and ERCC8 (p=0.0493; 95% CI=0.000303 to 0.0000007) genes were significantly associated with the presence of chromosomal abnormalities (see figure 2A-C).
Low expression was considered when the mean of values of ATM, LIG4 and ERCC8 gene expressions were significantly lower than the mean observed for patients with hMDS with or without presence of chromosomal abnormalities (table 3) .
Overall survival by Cutoff Finder of DNA repair genes in patients with MDS
We determined the cutoff value using the Cutoff Finder biostatistical tool to discriminate survival by Kaplan-Meier with log-rank post-test 9 (table 4) . This method correlates the dichotomised biomarker with a binary outcome using logistic regression. 9 First, we selected 0.001638 as the optimal cutoff value for all subsequent analyses to differentiate between lower LIG4 (<0.001638) and higher LIG4 (>0.001638) gene expression ( figure 3A) . Overall, 36 (70.6%) patients with MDS were considered to be lower LIG4 and 15 (29.4%) considered higher LIG4 ( figure 3A, B) . Lower LIG4 patients with MDS were associated with a higher overall survival ( p=0.017; HR=2.42; 95% CI 1.14 to 5.13) (figure 3C). Asterisk in bold text indicates significant differences (p<0.05) between groups analysed by Student's t-test two sided. BMC, bone marrow cellularity; DSB, double-strand break genes related to double DNA strand break repair pathway; SSB, single-strand break genes related to single DNA strand break repair pathway.
Based on 0.001674 cutoff point value for XPA gene analysis, we found that there were 21 (41.2%) patients with a higher XPA and 30 (58.8%) patients with a lower XPA ( figure 3A, B) . We observed that higher XPA (>0.001674) patients with MDS were associated with a lower overall survival ( p=0.019; HR=3.23; 95% CI 1.15 to 9.06) ( figure 3E, F) .
No difference in overall survival was detected for other genes related to HR (ATM, BRCA1, BRCA2) and NER (ERCC8 and 
XPC)
when their values were dichotomised as biomarkers with a binary outcome using logistic regression (data not presented).
MLR analysis of expressions of DNA repair genes
The expression of genes related to DSBs (ATM, BRCA1, BRCA2, LIG4) and single-strand breaks (SSBs) (ERCC8, XPA, XPC) was divided into two groups: low and high expression, according to cutoff point established by Cutoff Finder biostatistical web application. 9 We identified two subgroups of patients according to gene expression: lower group (when expression was lower than or equal to the cutoff value) and higher group (when expression was higher than the cutoff value). 9 We detected that the decreased expression of BRCA2 ( p=0.004, OR=12.500, 95% CI 2.190 to 71.363) and ERCC8 ( p=0.030, OR=11.900, 95% CI 1.272 to 111.3512) genes were associated with diagnosis of hMDS (table 4) .
No significant associations were found between the ATM, BRCA1, LIG4, XPA and XPC expressions and the bone marrow cellularity by MLR analysis ( p>0.05) (table 3).
Correlations of the mRNA expressions of DNA repair genes in patients with MDS By Pearson's correlation analysis, we observed significant correlations between the DSB (ATM, BRCA1, BRCA2, LIG4) and SSB (ERCC8, XPA and XPC) genes in MDS, demonstrating that these genes work in a dependent manner as a cascade of events (table 5) .
We observed positive correlations between BRCA1 and BRCA2 (r=0.416; r 2 =0.173; p=0.007) (figure 4A), ATM and LIG4 (r=0.472; r 2 =0.222; p=0.001) (figure 4B); LIG4 and BRCA1 (r=0.333; r 2 =0.110; p=0.026) (figure 4C), LIG4 and BRCA2 (r=0.334; r 2 =0.111; p=0.025) ( figure 4D ), ATM and XPA (r=0.377; r 2 =0.142; p=0.008) (figure 4E), ATM and The plots were generated using the biostatistical tool Cutoff Finder software.
XPC (r=0.287; r 2 =0.082; p=0.046) (figure 4F), LIG4 and XPC (r=0.371; r 2 =0.137; p=0.007) (figure 4G) and XPA and XPC genes (r=0.895; r 2 =0.801; p=0.0000) (figure 4H).
DISCUSSION
We evaluated genes related to double and single DNA strand breaks in patients with MDS and detected that these genes are positively correlated and work in a dependent manner as a cascade of events and may be related to pathogenesis and prognosis of MDS. We found that genes recruited and activated by DNA double (ATM) and single (ERCC8) strand breaks are downregulated in hMDS. Ataxia telangiectasia mutated (ATM) is a serine/threonine protein kinase that, once activated, phosphorylates several key proteins that initiate activation of the DNA damage checkpoint, leading to cell cycle arrest, DNA repair or apoptosis. 19 25 ERCC8 (CSA), together with ERCC6 (CSB), is the cell signalling that begins the transcription-coupled repair subpathway of NER. 26 As both genes act as primary sensors of DNA lesions, we suggest that DNA repair is deficient in hMDS and DNA damage tends to accumulate. Importantly, we also found that for patients with hMDS with low expression of ATM and ERCC8 there was a significant association with the presence of chromosomal abnormalities, reinforcing the intrinsic link between single-and double-strand breaks in MDS, principally in hypoplastic MDS. SSBs are not usually associated with a major DNA lesion and, 19 consequently, chromosomal breaks, but may be the first step to a DSB if not properly corrected. 27 The estimated numbers of SSBs and spontaneous base losses in nuclear DNA are as high as 10 4 per cell per day. 19 If the cell signalling of this type of lesion shows low expression, it may help to increase the chance of DSBs and consequent chromosomal abnormalities, as presented here.
Among several protein complexes involved in HR repair pathways, BRCA1/2, which are members of the BRCA family, were initially identified as biomarkers of breast cancer. [28] [29] [30] BRCA1/2 work with proteins of the RAD complex to control of genomic stability. [28] [29] [30] To the best of our knowledge, this is the first report to demonstrate that both genes show low expression in hMDS and are intrinsically and positively correlated, reinforcing the suggestion that BRCA1/2 work in a similar way. This result also corroborates the importance of both genes in maintaining genomic stability because their low expression among patients reported here was associated with an increase of chromosomal abnormalities. The low expressions of BRCA1 and BRCA2 genes have also been reported in solid tumours, such as epithelial ovarian carcinoma, prostate cancer and breast cancer. 31 32 Using MLR analysis, we detected that decreased expression of BRCA2 was associated with an increased chance of developing hMDS with an OR of 12. We were initially surprised with this result because BRCA2 is associated with DNA repair, but Jeong et al 33 showed that BRCA2 deficiency leads to T cell loss and immune dysfunction. In a very elegant murine model, the researchers demonstrated that mice with deficiency of BRCA2 show reduction in splenic T cell number and less interferon γ and interleukin 4, suggesting a functional defect of BRCA2-deficient T cells.
33
BRCA2 deficiency mice showed a greatly reduced production of IgM (ninefold reduction) compared with IgG1 (threefold reduction) or IgG2a (less than threefold reduction) isotypes. 32 All these results suggest that BRCA2 is also linked to immune abnormalities. 32 As hMDS is considered an immune disorder, 34 35 our result, showing decreased expression of BRCA2 with increased chance of developing hMDS, was probably not obtained by chance. New reports and in vitro models are necessary to confirm our associations. LIG4 (DNA ligase 4) encodes a protein that is a DNA ligase which joins SSBs in a double-stranded polydeoxynucleotide in an ATP-dependent reaction. 36 This protein is essential for V(D)J recombination, generation of the T cell receptor, immunoglobulin molecules and DNA DSB repair through NHEJ. 36 We were interested to detect low expression of LIG4 among patients with hMDS because deficiency of LIG4 has been associated with pancytopenia, combined immunodeficiency, cellular radiosensitivity, and recently, its mutation was associated with alterations of T and B cell counts with an increased percentage of memory cells and hypogammaglobulinaemia, 37 all markers of immune dysregulation. Hypoplastic MDS is considered an 'autoimmune disorder' owing to the concept that T cells contribute to bone marrow failure and that T cell depleting agents, such as rabbit and equine antithymocyte globulin, are important options of treatment. 32 33 Importantly, we also detected among all patients evaluated (not only patients with hMDS) that correlation with the LIG4 gene occurred most often. It was positively correlated with ATM, BRCA1, BRCA2 and XPC genes, which are linked to HR and NER. These correlations demonstrate the important intrinsic relations between single and double DNA strand breaks in MDS, reinforcing the suggestion that these genes are all related to MDS pathogenesis.
We detected an increased expression of XPC and XPA in hMDS. Damage to DNA single strand that occurs in the genome is recognised by the XPC and XPE protein complexes, which are specific components of the global genome NER system. 26 38 The DNA helix is opened by the XPB and XPD helixes of the repair, allowing damage verification by the XPA protein. 26 38 So, one important cell signalling (XPC) and the 'check' (XPA) of NER are hyperactivated in hMDS. As expected, we also found that these two genes were also positively correlated. Using the Cutoff Finder biostatistical tool to discriminate the survival by Kaplan-Meier with log-rank post-test, we also found that patients with higher XPA (>0.001674) expression had a shorter overall survival ( p=0.019; HR=3.23; 95% CI 1.15 to 9.06). This method correlates the dichotomised biomarker with a binary outcome using logistic regression. 9 This is the first report to demonstrate the importance of the singlestrand DNA repair system in MDS and these modifications may be the first step in genomic instability which, if not properly corrected, would predispose to DSBs and, consequently, chromosomal abnormalities.
When evaluating patients with hMDS, most researchers have focused on evaluation of immunological abnormalities. 34-35 39 We show, for the first time, that genes related to DNA repair may also be associated with the pathogenesis of hMDS. Recently, Danjou et al, 39 evaluated a large cohort of patients with MDS exploring 147 954 single nucleotide polymorphisms localised in regions which display some degree of association with immunological disorders. One of the most significant results was related to the gene RTEL1, an ATP helicase implicated in telomere-length regulation, DNA repair and genomic instability. 39 Of utmost importance, mutations in RTEL1 are responsible for nail dystrophy, mucosal leucoplasia and progressive bone marrow failure, the hallmark of MDS. 39 The authors demonstrate the intrinsic association of immunological disorders and genes related to DNA repair, reinforcing our proposal that DNA repair genes may be intrinsically related to the pathogenesis of hMDS.
Our study has some limitations. Limitations due to sample size are common in scientific publications, as stated by Danjou et al 39 and Gonçalves et al. 40 We found significant associations and correlations, but the number of cases evaluated was low and we cannot exclude the possibility that the absence of associations related to other genes might be explained by this factor. We must also emphasise that the number of cases with hMDS was low, only nine cases. Hypolastic MDS is a rare entity among cases of MDS-<10% of cases-which makes it difficult to study large numbers.
We believe that the pathogenesis of hMDS is associated with an immune-mediated process, 34 and also with the repair mechanism of DSB and SSB lesions. One important question arises: might the expression of these genes be new biomarkers of MDS? New reports are necessary to confirm or not our results.
Take home messages
▸ Previously, our group has shown that double and single DNA strand breaks are related to the pathogenesis of myelodysplastic syndrome (MDS). ▸ Our study determined that DNA repair gene expressions are positively correlated and work in a dependent manner as a cascade of events and may be related to the pathogenesis and prognosis of MDS. ▸ To the best of our knowledge, our study demonstrates for the first time that hypoplastic MDS is associated with an immune-mediated process, and also with the repair mechanism of double-and single-strand breaks.
